GlassScriptPhysician profile
Tanner Coleman
NPI 1780156687
$2,254.79
in general payments reported to CMS, 2019-2025
22 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $729 · 2020: $93.28 · 2022: $108 · 2023: $608 · 2024: $465 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $857 · Travel and Lodging: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $857.49 |
| Travel and Lodging | $466.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $592.03 | 2023 | 5ms, Colink 2 |
| Medical Device Business Services, INC. | $259.99 | 2019 | |
| Mimedx Group, INC. | $173.32 | 2024-2025 | |
| Musculoskeletal Transplant Foundation INC. | $165.28 | 2019 | |
| Stryker Corporation | $151.47 | 2019-2024 | Actishield, Citrefix, N/A |
| Horizon Therapeutics Plc | $125.05 | 2019 | |
| Titan Surgical Group, LLC | $118.63 | 2024-2025 | |
| Tenex Health INC. | $93.28 | 2020 | |
| Advanced Oxygen Therapy INC. | $83.25 | 2022 | |
| Ani Pharmaceuticals, INC. | $74.63 | 2024-2025 | Purified Cortrophin Gel |
| Smith+Nephew, INC. | $63.56 | 2024-2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix, Pico 7 |
| Averitas Pharma INC. | $50.16 | 2023-2025 | Qutenza |
| Amgen INC. | $49.99 | 2025 | Uplizna |
| Arthrex, INC. | $47.51 | 2019 | |
| Depuy Synthes Sales INC. | $46.02 | 2024 | Motoband, Speed, Foot Osteotomy Wedge System |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $33.01 | 2024 | Novosorb Btm |
| Medela LLC | $32.67 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $25.73 | 2025 | |
| Grt US Holding, INC. | $25.05 | 2022 | |
| Zyla Life Sciences, INC. | $15.65 | 2019 | |
| Acera Surgical, INC. | $15.27 | 2024 | Restrata Wound Matrix |
| Acell, INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tanner Coleman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.